Trial intelligence / Profile preview

Iodine Impregnated Drapes in Primary Total Shoulder Arthroplasty

NCT07721415Phase 4Enrolling by invitation

Sponsor
Nimbus Therapeutics
Start
Jan 2026
Primary completion
Dec 2029
Countries
1
01

Overview

A Phase 4 trial of iodine in surgical site infection (SSI), sponsored by Nimbus Therapeutics. Started Jan 2026; status: enrolling by invitation.

02

Drugs

iodine
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on NCT07721415.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07721415.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call